1. Home
  2. CGEM vs HIPO Comparison

CGEM vs HIPO Comparison

Compare CGEM & HIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$14.87

Market Cap

780.4M

Sector

Health Care

ML Signal

N/A

Logo Hippo Holdings Inc.

HIPO

Hippo Holdings Inc.

N/A

Current Price

$26.14

Market Cap

700.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CGEM
HIPO
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
780.4M
700.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CGEM
HIPO
Price
$14.87
$26.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$29.89
$37.25
AVG Volume (30 Days)
780.3K
141.2K
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$25.94
Revenue Next Year
N/A
$24.27
P/E Ratio
N/A
$7.64
Revenue Growth
N/A
N/A
52 Week Low
$5.68
$19.92
52 Week High
$16.74
$38.98

Technical Indicators

Market Signals
Indicator
CGEM
HIPO
Relative Strength Index (RSI) 57.60 34.58
Support Level $6.65 $25.28
Resistance Level $16.74 $31.61
Average True Range (ATR) 1.09 1.23
MACD -0.00 -0.17
Stochastic Oscillator 58.17 13.68

Price Performance

Historical Comparison
CGEM
HIPO

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

Share on Social Networks: